Chicago Rivet & Machine (CVR) vs Niki BioSolutions (NIKI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Chicago Rivet & Machine (CVR) has outperformed Niki BioSolutions (NIKI) over the past year, gaining 12.0% versus a loss of 83.1%. Over five years, CVR leads with a -56.7% price change compared with -98.5% for NIKI. Niki BioSolutions is the larger company by market cap ($12.5 million vs $10.8 million), about 1.2 times the size.
Chicago Rivet & Machine pays a dividend yielding 0.80%, while Niki BioSolutions does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVR | NIKI |
|---|---|---|
| Share price | $11.20 | $4.00 |
| Market cap | $10.82M | $12.47M |
| 1-day change | -3.24% | -7.41% |
| YTD return | -19.48% | -62.26% |
| 1-year return | +12.00% | -83.12% |
| 5-year return | -56.67% | -98.46% |
| EPS (TTM) | $-2.45 | $-2.90 |
| Dividend yield | 0.80% | 0.00% |
| Annual dividend | $0.09 | $0.00 |
| 52-week high | $15.00 | $17.60 |
| 52-week low | $8.50 | $4.00 |
| Distance from 52-week high | -25.33% | -77.27% |
| Average volume | 2.86K | 160.00K |
| Shares outstanding | 966.13K | 2.94M |
| Employees | 158 | 1 |
| Sector | Industrials | Industrials |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CVR has outperformed NIKI by 95.1 percentage points over the past year.
About Chicago Rivet & Machine
CVR stock →Chicago Rivet & Machine Co. operates in the fastener industry in North America.
Industrials · Industrial Machinery/Components · 158 employees
About Niki BioSolutions
NIKI stock →Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa.
Industrials · Industrial Machinery/Components · 1 employees
CVR vs NIKI FAQ
Which is bigger, Chicago Rivet & Machine or Niki BioSolutions?
Niki BioSolutions (NIKI) is larger, with a market capitalization of $12.47M compared with $10.82M for Chicago Rivet & Machine (CVR).
Which stock has performed better over the past year, CVR or NIKI?
CVR returned +12.00% over the past 12 months, compared with -83.12% for NIKI (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Chicago Rivet & Machine or Niki BioSolutions?
Chicago Rivet & Machine pays a dividend yielding 0.80%, while Niki BioSolutions does not currently pay a regular dividend.
Are Chicago Rivet & Machine and Niki BioSolutions in the same industry?
Yes. Both are classified in the Industrial Machinery/Components industry within the Industrials sector.